安徽建工(600502.SH):聯合體合計中標32.42億元工程項目
格隆匯3月15日丨安徽建工(600502.SH)公佈,近日,公司及公司控股子安徽省路橋工程集團有限責任公司、安徽省公路橋樑工程有限公司和安徽三建工程有限公司收到工程中標通知書。
一、G312合六界至迎賓大道交口段快速化改造工程施工
項目中標人:公司控股子安徽省路橋工程集團有限責任公司(牽頭人)與衡宇建設集團有限公司聯合體;中標價:16.71億元。
二、桃花科創產業園EPC
項目中標人:公司控股子公司安徽省公路橋樑工程有限公司(牽頭人)和安徽三建工程有限公司與深圳市建築設計研究總院有限公司聯合體;中標價:15.71億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.